Venous access devices are specifically-designed catheters to gain and maintain access to the venous system. Venous access devices are of two types: central venous catheters and peripheral venous catheters. Peripheral venous catheters are inserted by percutaneous venipuncture, generally into a hand or arm vein. These are generally 3 to 10 inches in length. The tip of these catheters does not allow penetration beyond the axillary line, thereby restricting infusates, such as, vesicants and drugs that could cause irritation and harm to the peripheral veins. Infusates utilized by these catheters primarily include antibiotics, antipyretics, and analgesics. As peripheral venous catheters are not inserted into the central veins, they can be positioned without using an X-ray device for confirming their placement. Peripheral venous catheters are advantageous over other types of catheters as the former does not possess the risk of causing phlebitis or infections and can be placed in the veins for an extended duration of time (seven days or more).
The global peripheral venous access devices market can be segmented on the basis of product type, application, end-user, and region. Based on product type, the peripheral venous access devices market can be divided into peripheral short catheter, peripheral midline catheter, and peripherally inserted central catheter (PICC). In terms of application, the peripheral venous access devices market can be categorized into drug administration, fluid and nutrition administration, diagnostics and testing, and others. On the basis of end-user, the market can be classified into hospitals, ambulatory surgical centers, specialty clinics, and others. Based on geography, the market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Technological advancements in infusion pumps and catheter are likely to augment the demand for peripheral catheters in the market. Development in making infusion pumps more precise and accurate has reduced the incidence of overdose and its related issues. This has increased their demand in the market as a treatment option for chronic pain and diabetes. Furthermore, implantation of these pumps is minimally invasive which has increased their acceptance and adoption, thereby boosting the market growth. Likewise, availability of catheters in different gauge sizes has augmented the growth of the peripheral catheter market. Size variation in catheters is meant to serve a specific purpose, which increases the accuracy of administration of medication, thus increasing the safety.
On the basis of geography, North America is expected to account for the dominant share of the global peripheral venous access devices market during the forecast period. This can be attributed to the large number of patients suffering from chronic diseases, such as, diabetes, hypertension, and cancer in the region. Moreover, major market players, such as, C. R. Bard, Inc. and Becton Dickinson and Company (BD) are based in the U.S. which further supports the high market share of the region. The peripheral venous access devices market in Asia Pacific is expected to expand at a significant CAGR in the next few years. India, China, and other Asian countries have reported rise in disposable income due to economic development. This has boosted the purchasing power of people for medical services. As such, this has augmented the preference of administration of medication via intravenous access (IV) devices, which is likely to propel the growth of the peripheral venous access devices market in the region. Similarly, increase in health care expenditure is estimated to boost the utilization of infusion pumps and catheters in hospitals, contributing to the growth of the market during the forecast period. Other regions, such as Middle East & Africa and Latin America, are expected to be the prospective markets in the near future due to the high adoption rate of advanced therapeutics and rapidly developing health care industry in these regions.
Major players operating in the global peripheral venous access devices market include AngioDynamics, Abbott Laboratories, C. R. Bard, Inc., Cook Group Incorporated, Boston Scientific Corporation, Becton Dickinson and Company, Baxter International Inc., Smiths Medical, and Teleflex Incorporated.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.